German non-profit organization DEBRA Research GmbH, supporting those affected by epidermolysis bullosa (EB), and Denmark’s LEO Pharma announced a non-exclusive strategic partnership.

A class action settlement has been reached in Stewart v. LEO Pharma Inc. et al, S.C.B.C. No. S2010053 (the "Claim").

Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Empower, a leader in the compounding pharmacy and pharmaceutical manufacturing industries, is excited to announce the launch of its refreshed corporate logo, marking a significant step in the ...

Discover why FMC is a compelling deep-value play with a 6.5% yield despite recent challenges in the ag markets. Click here to ...

Keratosis - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides top line data relating to the clinical trials on ...

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.

DEBRA Research and LEO Pharma announce strategic partnership to enhance treatments for Epidermolysis Bullosa (EB), a rare skin disease with no approved treatment options ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 21,148.40 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Company has S R B C & Co. LLP as its auditors. As on 31-12-2024, the company has a total of 239.93 Crore shares outstanding.Sun Pharma Share Price Today is Rs. 1765.25. On previous day, the Sun Pharma ...